AACR logo

More articles from Research Articles: Targets

Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells
Tae-Jin Lee, Eun Jung Kim, Shin Kim, Eun Mi Jung, Jong-Wook Park, Seung Hun Jeong, Sang Eun Park, Young Hyun Yoo, Taeg Kyu Kwon

Molecular Cancer Therapeutics Sep 2006, 5 (9) 2398-2407; DOI: 10.1158/1535-7163.MCT-06-0167
Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus
Matthew A. Tyler, Ilya V. Ulasov, Anton Borovjagin, Adam M. Sonabend, Andrey Khramtsov, Yu Han, Paul Dent, Paul B. Fisher, David T. Curiel, Maciej S. Lesniak

Molecular Cancer Therapeutics Sep 2006, 5 (9) 2408-2416; DOI: 10.1158/1535-7163.MCT-06-0187
Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues
Ruili Huang, Anders Wallqvist, David G. Covell

Molecular Cancer Therapeutics Sep 2006, 5 (9) 2417-2427; DOI: 10.1158/1535-7163.MCT-06-0239
Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2
Changjiang Xu, Xiaoling Yuan, Zui Pan, Guoxiang Shen, Jung-Hwan Kim, Siwang Yu, Tin Oo Khor, Wenge Li, Jianjie Ma, Ah-Ng Tony Kong

Molecular Cancer Therapeutics Aug 2006, 5 (8) 1918-1926; DOI: 10.1158/1535-7163.MCT-05-0497
A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes
Michael J. Ausserlechner, Petra Obexer, Andrea Deutschmann, Kathrin Geiger, Reinhard Kofler

Molecular Cancer Therapeutics Aug 2006, 5 (8) 1927-1934; DOI: 10.1158/1535-7163.MCT-05-0500
Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase–activated protein kinase 2 in mediating DNA damage–induced cell cycle arrest: implications for cancer therapy
Zhan Xiao, John Xue, Thomas J. Sowin, Haiying Zhang

Molecular Cancer Therapeutics Aug 2006, 5 (8) 1935-1943; DOI: 10.1158/1535-7163.MCT-06-0077
Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells
Maria Antonietta Cerone, J. Arturo Londoño-Vallejo, Chantal Autexier

Molecular Cancer Therapeutics Jul 2006, 5 (7) 1669-1675; DOI: 10.1158/1535-7163.MCT-06-0033
Regulatory role of c-Met in insulin-like growth factor-I receptor–mediated migration and invasion of human pancreatic carcinoma cells
Todd W. Bauer, Ray J. Somcio, Fan Fan, Wenbiao Liu, Marjorie Johnson, Donald P. Lesslie, Douglas B. Evans, Gary E. Gallick, Lee M. Ellis

Molecular Cancer Therapeutics Jul 2006, 5 (7) 1676-1682; DOI: 10.1158/1535-7163.MCT-05-0175
Discovery and characterization of inhibitors of human palmitoyl acyltransferases
Charles E. Ducker, Lindsay K. Griffel, Ryan A. Smith, Staci N. Keller, Yan Zhuang, Zuping Xia, John D. Diller, Charles D. Smith

Molecular Cancer Therapeutics Jul 2006, 5 (7) 1647-1659; DOI: 10.1158/1535-7163.MCT-06-0114
Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice
Syed M. Meeran, Suchitra Katiyar, Craig A. Elmets, Santosh K. Katiyar

Molecular Cancer Therapeutics Jul 2006, 5 (7) 1660-1668; DOI: 10.1158/1535-7163.MCT-06-0095

Main menu

User menu

Search

More articles from Research Articles: Targets

Pages

Articles

Info for

About MCT